Literature DB >> 22704276

[Life-threatening hemoptysis: study of 154 patients].

Ramon Orriols1, Víctor Núñez, Rosana Hernando, Estrella Drobnic, Margarita Moreiras.   

Abstract

BACKGROUND AND OBJECTIVES: The natural history of life-threatening hemoptysis (LTH), a medical emergency, is ill defined. The objective of the study was to evaluate, in a university teaching hospital setting, the etiology, methods used, and evolution of LTH. PATIENTS AND METHODS: Prospective study in which we enrolled 154 patients admitted for LTH over 3 consecutive years. Bronchoscopy and arteriography procedures were performed, as prescribed by the attending physician. Patient evolution was followed 5 years post-event. RESULT: 79.2% were male. Average age was 57 (SD 15) years. Bronchiectasis and active tuberculosis and its consequences were the predominant etiologies. A total of 4.5% patients died as a result of LTH. Bronchoscopy was more effective in identifying the bleeding than arteriography when the examination was performed during an episode of hemoptysis (84.2 versus 20.4%) (P<.001). When embolization or bronchoscopy were used as first measure, embolization was more effective in stabilizing bleeding than bronchoscopy (87 versus 53.5%) (P<.001) in admitted patients. LTH relapse was 10.7%, while it was lower with embolization.
CONCLUSIONS: Leading causes were bronchiectasis and tuberculosis. While bronchoscopy during a hemoptysis episode was effective in identifying the source of the bleeding, artery embolization was more effective in stabilizing the patient both at the short and long term.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22704276     DOI: 10.1016/j.medcli.2012.01.031

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  Bronchiectasis: a bacteriological profile.

Authors:  Régis Gothard Bopaka; Wiam El Khattabi; Hind Janah; Hasna Jabri; Hicham Afif
Journal:  Pan Afr Med J       Date:  2015-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.